CCL conjures up two key levels as we look at this bounce: if gets through $20, watch out for $30. The short interest here has to be quite crowded. But that's the case for a reason.
Dates in the future with the highest probability for price direction reversals
Dates in the future with the highest probability for price direction reversals
Dates in the future with the highest probability for price direction reversals
Took my first dip into the Cruise companies sticking with the top players and the one that just secured liquidity facilities yesterday , also expect the US government support for these too Any positive news can double your investment in no time , otherwise good LT holdings if don't go into bankruptcy of Course lolll Took equal weight each , will add if...
... for a 2.43 credit. Notes: High rank/implied at 99/80. With a current yield of 5.30%, I'm fine with taking on stock here with a cost basis of 27.57 if that ends up happening.
I drew up this chart last month and wrote that $22 CCL would be a buy in 2021. Well looks like $22 came 1 month later and really not feeling to confident in buying here looks like big problems might be ahead. Conversely if CCL does bounce here then I would assume that the market thinks Coronavirus is finally getting under control
CCL has a constructive longer-term pattern in play into this headline-driven drop. A vaccine may not be far off for Wuhan Coronavirus. Keep this one on the radar.
Showing good divergence on weekly and coming off historical support
Luego del derrumbe post Paso (tomado todo como onda A) el rebote en ‘pisos‘ fue una onda B, ante la potencial victoria del candidato Fernandez podemos intuir que la alta volatilidad del mercado acelere la onda C (bajista en este caso) pero en escenarios con eventos de alta volatilidad recomiendo NO OPERAR a menos que se este dispuesto a correr riesgos de perdida...
CCL Products looks like a good opportunity to BUY at current price.
CCL had a good run since since 2014 but is flat-lining at the tail end of an extended ABCD formation. High of c.$73 was a stretched 138.2% CD extension with price action range bound since Sep 2017. CCL and competitors have been aggressively adding capacity over the last few years which you would expect severe operational deleveraging in the event of a dry spell....
Theyve started to gap it up on daily opens - thats bad, very very bad Chart has notes